Green Valley Investors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $52.1M | Buy |
307,761
+102,505
| +50% | +$17.4M | 2.96% | 13 |
|
|
2019
Q2 | $37.6M | Sell |
205,256
-34,265
| -14% | -$6.28M | 2.14% | 19 |
|
|
2019
Q1 | $44.1M | Hold |
239,521
| – | – | 2.25% | 19 |
|
|
2018
Q4 | $39.7M | Sell |
239,521
-61
| -0% | -$10.1K | 2.28% | 18 |
|
|
2018
Q3 | $46.2M | Sell |
239,582
-18,837
| -7% | -$3.63M | 2.06% | 18 |
|
|
2018
Q2 | $43.9M | Sell |
258,419
-18,235
| -7% | -$3.1M | 2.06% | 19 |
|
|
2018
Q1 | $45.1M | Buy |
276,654
+156,400
| +130% | +$25.5M | 2.15% | 16 |
|
|
2017
Q4 | $18M | Sell |
120,254
-9,490
| -7% | -$1.42M | 0.86% | 27 |
|
|
2017
Q3 | $19.7M | Sell |
129,744
-55,686
| -30% | -$8.47M | 0.96% | 26 |
|
|
2017
Q2 | $23.9M | Sell |
185,430
-7,271
| -4% | -$937K | 1.16% | 25 |
|
|
2017
Q1 | $21.1M | Sell |
192,701
-2,576
| -1% | -$282K | 1.04% | 26 |
|
|
2016
Q4 | $14.4M | Sell |
195,277
-40,398
| -17% | -$2.98M | 0.76% | 27 |
|
|
2016
Q3 | $20.6M | Sell |
235,675
-105,855
| -31% | -$9.23M | 1.05% | 23 |
|
|
2016
Q2 | $29.4M | Sell |
341,530
-117,768
| -26% | -$10.1M | 0.9% | 25 |
|
|
2016
Q1 | $36.5M | Sell |
459,298
-40,702
| -8% | -$3.24M | 0.89% | 23 |
|
|
2015
Q4 | $62.9M | Hold |
500,000
| – | – | 1.29% | 23 |
|
|
2015
Q3 | $52.1M | Hold |
500,000
| – | – | 1.12% | 23 |
|
|
2015
Q2 | $61.7M | Hold |
500,000
| – | – | 1.19% | 25 |
|
|
2015
Q1 | $59M | Hold |
500,000
| – | – | 1.18% | 23 |
|
|
2014
Q4 | $59.4M | Hold |
500,000
| – | – | 1.25% | 24 |
|
|
2014
Q3 | $56.2M | Hold |
500,000
| – | – | 1.28% | 23 |
|
|
2014
Q2 | $47.3M | Sell |
500,000
-500,000
| -50% | -$47.3M | 1.1% | 25 |
|
|
2014
Q1 | $70.7M | Sell |
1,000,000
-791,786
| -44% | -$56M | 1.62% | 24 |
|
|
2013
Q4 | $133M | Hold |
1,791,786
| – | – | 2.9% | 16 |
|
|
2013
Q3 | $136M | Sell |
1,791,786
-708,214
| -28% | -$53.7M | 3.34% | 14 |
|
|
2013
Q2 | $200M | Buy |
+2,500,000
| New | +$200M | 4.89% | 6 |
|